Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Calgary

$24,000.00

Role of placental lactogens in regulating pancreatic beta-cell mass and function

FY 2019-20

Summary
Pancreatic islets contain ß cells that synthesize insulin, the hormone responsible for maintaining normal blood glucose. We know that ß-cell mass and function is dynamic, and it can adapt to stresses such as pregnancy by increasing ß-cell mass and insulin secretion. We endeavor to study how ß-cell responds to its environment and mechanisms that regulate ß-cell mass and function. Previously, our studies have found that mice with a heterozygous deletion of prolactin receptor (Prlr), i.e. the Prlr+/- mice, had lower ß-cell number and secreted less insulin than wild type mice during pregnancy, suggesting that placental lactogens (PLs), which act on Prlr, have biological effects on ß cells. Since the Prlr deletion is in the whole body, not pancreas-specific, it is possible that the phenotype is secondary to overall diminished Prlr-mediated effects. To determine the mechanisms mediating ß-cell adaptation during pregnancy, I am seeking to discover the mechanism of how PLs regulate ß-cell mass and function. Our overall hypothesis is that PLs act directly on ß cells through its receptor (i.e. Prlr) to stimulate proliferation, insulin synthesis and secretion in adaptation to pregnancy. ***The long term objective of my research program is to understand the molecular mechanisms that control ß-cell growth and development. Our short term objectives are to study how PLs regulate ß-cell mass expansion and the molecular mechanisms involved.***Aim 1. To determine the source of new ß cells in pregnancy. Using a transgenic mouse, we will tag ß cells that express a stem cell marker and then we will determine if these stem cells will develop into ß cells. ***Aim 2a. Characterize ß-cell mass and function in pancreas-specific Prlr-null mice. Using a transgenic mouse whereby Prlr will be deleted specifically from the pancreas after a drug is given, we will determine whether PLs regulate ß-cell proliferation by examining ß-cell mass and replication index. The impact of PLs on glucose homeostasis will be assessed by glucose and insulin tolerance tests. ***Aim 2b. Determine the molecular pathways regulated by Prlr in pancreatic ß cells. Many genes have been shown to regulate ß-cell biology during pregnancy. To determine which are Prlr-specific targets, we will compare their expression levels among the Prlr-null, pancreatic-specific Prlr-null and wild type mice. ***Aim 2c. To identify novel Prlr targets. A high throughput method will be used to screen for genes that are differentially expressed between pancreatic-specific Prlr-null and wild type mice. Genes that are identified as Prlr targets will be stratified based on putative function and further studied using pharmacological inhibitors or genetically-mediated gene deletion to determine their function. ***Results from this project will significantly advance our understanding of how ß-cell responds to its environment in adaptation to stresses. **
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2015-04937
Name nom
Huang, CarolTzuLing
Department département
Paediatrics
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2015
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal physiology and metabolism
Research subject fr
Physiologie et métabolisme des animaux
Installment
inst:5 - 5
Partie
5
Nb partie
5
Application title
Role of placental lactogens in regulating pancreatic beta-cell mass and function
Keyword
NSERC
Application summary
Pancreatic islets contain ß cells that synthesize insulin, the hormone responsible for maintaining normal blood glucose. We know that ß-cell mass and function is dynamic, and it can adapt to stresses such as pregnancy by increasing ß-cell mass and insulin secretion. We endeavor to study how ß-cell responds to its environment and mechanisms that regulate ß-cell mass and function. Previously, our studies have found that mice with a heterozygous deletion of prolactin receptor (Prlr), i.e. the Prlr+/- mice, had lower ß-cell number and secreted less insulin than wild type mice during pregnancy, suggesting that placental lactogens (PLs), which act on Prlr, have biological effects on ß cells. Since the Prlr deletion is in the whole body, not pancreas-specific, it is possible that the phenotype is secondary to overall diminished Prlr-mediated effects. To determine the mechanisms mediating ß-cell adaptation during pregnancy, I am seeking to discover the mechanism of how PLs regulate ß-cell mass and function. Our overall hypothesis is that PLs act directly on ß cells through its receptor (i.e. Prlr) to stimulate proliferation, insulin synthesis and secretion in adaptation to pregnancy. ***The long term objective of my research program is to understand the molecular mechanisms that control ß-cell growth and development. Our short term objectives are to study how PLs regulate ß-cell mass expansion and the molecular mechanisms involved.***Aim 1. To determine the source of new ß cells in pregnancy. Using a transgenic mouse, we will tag ß cells that express a stem cell marker and then we will determine if these stem cells will develop into ß cells. ***Aim 2a. Characterize ß-cell mass and function in pancreas-specific Prlr-null mice. Using a transgenic mouse whereby Prlr will be deleted specifically from the pancreas after a drug is given, we will determine whether PLs regulate ß-cell proliferation by examining ß-cell mass and replication index. The impact of PLs on glucose homeostasis will be assessed by glucose and insulin tolerance tests. ***Aim 2b. Determine the molecular pathways regulated by Prlr in pancreatic ß cells. Many genes have been shown to regulate ß-cell biology during pregnancy. To determine which are Prlr-specific targets, we will compare their expression levels among the Prlr-null, pancreatic-specific Prlr-null and wild type mice. ***Aim 2c. To identify novel Prlr targets. A high throughput method will be used to screen for genes that are differentially expressed between pancreatic-specific Prlr-null and wild type mice. Genes that are identified as Prlr targets will be stratified based on putative function and further studied using pharmacological inhibitors or genetically-mediated gene deletion to determine their function. ***Results from this project will significantly advance our understanding of how ß-cell responds to its environment in adaptation to stresses. **